Q14653 (IRF3_HUMAN) Homo sapiens (Human)
Interferon regulatory factor 3 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
18 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Phosphorylated TRIF in complex with IRF-3 |
Heteromer Q8IUC6; | |||||
| Assess | ||||||
| Phosphorylated Rotavirus NSP1 in complex with IRF-3 |
Heteromer Q99FX5; | 3×PO4; | ||||
| Assess | ||||||
| Phosphorylated STING in complex with IRF-3 CTD |
Heteromer Q86WV6; | |||||
| Assess | ||||||
| Phosphorylated MAVS in complex with IRF-3 |
Heteromer Q7Z434; | |||||
| Assess | ||||||
| Structure of Rotavirus NSP1 bound to IRF-3 |
Heteromer Q99FX5; | |||||
| Assess | ||||||
| Complex of IRF-3 with CBP |
Heteromer Q92793; | |||||
| Assess | ||||||
| Crystal structure of human phosphorylated IRF-3 bound to CBP |
Heteromer Q92793; | |||||
| Assess | ||||||
| IRF3-CBP complex |
Heteromer Q92793; | |||||
| Assess | ||||||
| Structure Of The DNA Binding Domains Of IRF3, ATF-2 and Jun Bound To DNA |
Heteromer P05412; P15336; | |||||
| Assess | ||||||
| Crystal Structure of NFkB, IRF7, IRF3 bound to the interferon-b enhancer |
Heteromer P19838; Q04206; Q92985; | |||||
| Assess | ||||||
| Structure of HPV16 E6 oncoprotein in complex with IRF3 LxxLL motif |
Heteromer P03126; P0AEX9; | 1×GLC; 2×ZN; | ||||
| Assess | ||||||
| Structure of HPV16 E6 oncoprotein in complex with mutant IRF3 LxxLL motif |
Heteromer P03126; P0AEX9; | 1×GLC; 2×ZN; | ||||
| Assess | ||||||
| Crystal Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-B enhan… | homo-4-mer | |||||
| Assess | ||||||
| Crystal structure of IRF-3 bound to the interferon-b enhancer | homo-4-mer | |||||
| Assess | ||||||
| Auto-inhibitory interferon regulation factor-3 (IRF3) transactivation domain | homo-2-mer | 8×PO4; | ||||
| Assess | ||||||
| The crystal structure of phosphorylated IRF-3 | monomer | 1×ACY; 1×MPD; | ||||
| Assess | ||||||
| X-ray crystal structure of IRF-3 and its functional implications | monomer | |||||
| Assess | ||||||
| Crystal structure of IRF-3 DBD free form | monomer | 4×ZN; 4×CL; 2×NA; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1qwt.1.A | homo-2-mer | 0.82 | 100.00 | |||
| Assess | ||||||
| 7jfm.1.C | monomer | 0.77 | 75.36 | |||
| Assess | ||||||
| 2pi0.1.D | monomer | 0.73 | 100.00 | |||
| Assess | ||||||
7 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 2pi0.1.D | monomer | 0.73 | 100.00 | ||
| Assess | ||||||
| Isoform 2 | 3a77.2.A | monomer | 0.55 | 97.09 | ||
| Assess | ||||||
| Isoform 3 | 1qwt.1.A | homo-2-mer | 0.68 | 99.01 | ||
| Assess | ||||||
| Isoform 3 | 7jfm.1.C | monomer | 0.54 | 80.28 | ||
| Assess | ||||||
| Isoform 4 | 2o6g.1.D | monomer | 0.74 | 100.00 | ||
| Assess | ||||||
| Isoform 4 | 1j2f.2.A | monomer | 0.71 | 79.38 | ||
| Assess | ||||||
| Isoform 5 | 2pi0.1.D | monomer | 0.67 | 88.71 | ||
| Assess | ||||||